Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Mar;27(3):367-83.
doi: 10.1007/s10554-010-9658-4. Epub 2010 Jun 25.

Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium

Tycho I G van der Spoel  1 , Joe Chun-Tsu Lee, Krijn Vrijsen, Joost P G Sluijter, Maarten Jan M Cramer, Pieter A Doevendans, Eric van Belle, Steven A J Chamuleau
Affiliations
Review

Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium

Tycho I G van der Spoel et al. Int J Cardiovasc Imaging. 2011 Mar.

Abstract

Heart failure is a major economic and public health problem. Despite the recent advances in drug therapy and coronary revascularization, the lost cardiomyocytes due to necrosis and apoptosis are not replaced by new myocardial tissue. Cell therapy is an interesting therapeutic option as it potentially improves contractility and restores regional ventricular function. Early clinical data demonstrated that cell transplantation, mainly delivered through non-surgical methods, is safe and feasible. However, several important issues need to be elucidated. This includes, next to determining the best cell type, the optimal delivery strategy, the biodistribution and the survival of implanted stem cells after transplantation. In this view, pre-clinical animal experiments are indispensable. Reporter genes, magnetic or radioactive labeling of stem cells have been developed to observe the fate and the distribution of transplanted cells using non-invasive imaging techniques. Several studies have demonstrated that these direct and non-direct labeling techniques may become an important tool in cell therapy. Integration of cell delivery and cell tracking will probably be a key for the success of cell therapy in patients. This review will provide a comprehensive overview on the various cell tracking and non-surgical cell delivery techniques, which are highly important in view of experimental and clinical studies.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Different methods for non-invasive cell tracking. a MRI magnetic resonance imaging, SPIO super paramagnetic iron oxide; b SPECT single photon emission computer tomography, indium 111 In111, 99Tc 99Technetium, PET positron emission tomography, 18 F FDG 18F-fluorodeoxyglucose; c RPG reporter gene
Fig. 2
Fig. 2
T2* image of SPIO labeled MSC (arrow) after transepicardial injection in healthy myocardium
Fig. 3
Fig. 3
SPECT image of indium111 labeled MSC in the heart after surgical injection in the left ventricle wall in a healthy porcine model
Fig. 4
Fig. 4
Schematic overview of the different delivery techniques to the injured myocardium. a Intravenous infusion b Trans-endocardial delivery c Surgical delivery d Intracoronary infusion e Retrograde coronary transvenous injection
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O’Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y, for the American Heart Association Statistics Committee, Stroke Statistics Subcommittee Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–146. doi: 10.1161/CIRCULATIONAHA.107.187998. - DOI - PubMed
    1. World Health Organization (2007) The atlas of heart disease and stroke. pp 48–49
    1. Halkos M, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey L, Martin B, Quyyumi A, Few W, Kin H, Guyton R, Vinten-Johansen J. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol. 2008;103:525–536. doi: 10.1007/s00395-008-0741-0. - DOI - PubMed
    1. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB, Jr, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277–2286. doi: 10.1016/j.jacc.2009.06.055. - DOI - PMC - PubMed
    1. Perin EC, Dohmann HFR, Borojevic R, Silva SA, Sousa ALS, Mesquita CT, Rossi MID, Carvalho AC, Dutra HS, Dohmann HJF, Silva GV, Belem L, Vivacqua R, Rangel FOD, Esporcatte R, Geng YJ, Vaughn WK, Assad JAR, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003;107:2294–2302. doi: 10.1161/01.CIR.0000070596.30552.8B. - DOI - PubMed

Publication types